{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:32:16Z","timestamp":1793831536897,"version":"4.6.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"8105","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2026,3,12]]},"DOI":"10.1038\/s41586-025-09926-8","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:01:21Z","timestamp":1768406481000},"page":"451-461","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The ubiquitin ligase KLHL6 drives resistance to CD8+ T cell dysfunction"],"prefix":"10.1038","volume":"651","author":[{"given":"Hongcheng","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yapeng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3867-0232","authenticated-orcid":false,"given":"Raphael","family":"Gottardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3812-647X","authenticated-orcid":false,"given":"Philip D.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0840-7262","authenticated-orcid":false,"given":"Guideng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"9926_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41571-023-00832-4","volume":"21","author":"SM Albelda","year":"2024","unstructured":"Albelda, S. M. CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn. Nat. Rev. Clin. Oncol. 21, 47\u201366 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"9926_CR2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1146\/annurev-immunol-090222-110914","volume":"42","author":"A Baessler","year":"2024","unstructured":"Baessler, A. & Vignali, D. A. A. T cell exhaustion. Annu. Rev. Immunol. 42, 179\u2013206 (2024).","journal-title":"Annu. Rev. Immunol."},{"key":"9926_CR3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41590-020-00834-9","volume":"22","author":"NE Scharping","year":"2021","unstructured":"Scharping, N. E. et al. Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion. Nat. Immunol. 22, 205\u2013215 (2021).","journal-title":"Nat. Immunol."},{"key":"9926_CR4","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/s41590-020-0725-2","volume":"21","author":"SA Vardhana","year":"2020","unstructured":"Vardhana, S. A. et al. Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen. Nat. Immunol. 21, 1022\u20131033 (2020).","journal-title":"Nat. Immunol."},{"key":"9926_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42634-3","volume":"14","author":"H Wu","year":"2023","unstructured":"Wu, H. et al. Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1alpha-mediated glycolytic reprogramming. Nat. Commun. 14, 6858 (2023).","journal-title":"Nat. Commun."},{"key":"9926_CR6","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41590-020-0793-3","volume":"21","author":"YR Yu","year":"2020","unstructured":"Yu, Y. R. et al. Disturbed mitochondrial dynamics in CD8(+) TILs reinforce T cell exhaustion. Nat. Immunol. 21, 1540\u20131551 (2020).","journal-title":"Nat. Immunol."},{"key":"9926_CR7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41586-019-1325-x","volume":"571","author":"O Khan","year":"2019","unstructured":"Khan, O. et al. TOX transcriptionally and epigenetically programs CD8(+) T cell exhaustion. Nature 571, 211\u2013218 (2019).","journal-title":"Nature"},{"key":"9926_CR8","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nature22367","volume":"545","author":"M Philip","year":"2017","unstructured":"Philip, M. et al. Chromatin states define tumour-specific T cell dysfunction and reprogramming. Nature 545, 452\u2013456 (2017).","journal-title":"Nature"},{"key":"9926_CR9","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41586-023-06733-x","volume":"624","author":"P Zhou","year":"2023","unstructured":"Zhou, P. et al. Single-cell CRISPR screens in vivo map T cell fate regulomes in cancer. Nature 624, 154\u2013163 (2023).","journal-title":"Nature"},{"key":"9926_CR10","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1126\/science.aar6711","volume":"359","author":"CH June","year":"2018","unstructured":"June, C. H., O\u2019Connor, R. S., Kawalekar, O. U., Ghassemi, S. & Milone, M. C. CAR T cell immunotherapy for human cancer. Science 359, 1361\u20131365 (2018).","journal-title":"Science"},{"key":"9926_CR11","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","volume":"186","author":"P Sharma","year":"2023","unstructured":"Sharma, P. et al. Immune checkpoint therapy-current perspectives and future directions. Cell 186, 1652\u20131669 (2023).","journal-title":"Cell"},{"key":"9926_CR12","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","volume":"19","author":"A Chow","year":"2022","unstructured":"Chow, A., Perica, K., Klebanoff, C. A. & Wolchok, J. D. Clinical implications of T cell exhaustion for cancer immunotherapy. Nat. Rev. Clin. Oncol. 19, 775\u2013790 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"9926_CR13","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abq3016","volume":"8","author":"JJ Peng","year":"2023","unstructured":"Peng, J. J., Wang, L., Li, Z., Ku, C. L. & Ho, P. C. Metabolic challenges and interventions in CAR T cell therapy. Sci. Immunol. 8, eabq3016 (2023).","journal-title":"Sci. Immunol."},{"key":"9926_CR14","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41568-021-00365-x","volume":"21","author":"B Dale","year":"2021","unstructured":"Dale, B. et al. Advancing targeted protein degradation for cancer therapy. Nat. Rev. Cancer 21, 638\u2013654 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"9926_CR15","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.1172\/JCI41991","volume":"120","author":"IM Stromnes","year":"2010","unstructured":"Stromnes, I. M. et al. Abrogating Cbl-b in effector CD8(+) T cells improves the efficacy of adoptive therapy of leukemia in mice. J. Clin. Invest. 120, 3722\u20133734 (2010).","journal-title":"J. Clin. Invest."},{"key":"9926_CR16","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/s41590-019-0469-z","volume":"20","author":"B Zhao","year":"2019","unstructured":"Zhao, B. et al. Notch and the pre-TCR coordinate thymocyte proliferation by induction of the SCF subunits Fbxl1 and Fbxl12. Nat. Immunol. 20, 1381\u20131392 (2019).","journal-title":"Nat. Immunol."},{"key":"9926_CR17","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1038\/s41590-025-02231-6","volume":"26","author":"MW LaFleur","year":"2025","unstructured":"LaFleur, M. W. et al. A STUB1-CHIC2 complex inhibits CD8(+) T cells to restrain tumor immunity. Nat. Immunol. 26, 1476\u20131487 (2025).","journal-title":"Nat. Immunol."},{"key":"9926_CR18","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1126\/science.aaf2807","volume":"354","author":"KE Pauken","year":"2016","unstructured":"Pauken, K. E. et al. Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade. Science 354, 1160\u20131165 (2016).","journal-title":"Science"},{"key":"9926_CR19","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.immuni.2012.08.021","volume":"37","author":"TA Doering","year":"2012","unstructured":"Doering, T. A. et al. Network analysis reveals centrally connected genes and pathways involved in CD8+ T cell exhaustion versus memory. Immunity 37, 1130\u20131144 (2012).","journal-title":"Immunity"},{"key":"9926_CR20","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/s41586-024-08562-y","volume":"640","author":"DT McManus","year":"2025","unstructured":"McManus, D. T. et al. An early precursor CD8(+) T cell that adapts to acute or chronic viral infection. Nature 640, 772\u2013781 (2025).","journal-title":"Nature"},{"key":"9926_CR21","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/s41586-024-08451-4","volume":"640","author":"T Chu","year":"2025","unstructured":"Chu, T. et al. Precursors of exhausted T cells are pre-emptively formed in acute infection. Nature 640, 782\u2013792 (2025).","journal-title":"Nature"},{"key":"9926_CR22","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe6474","volume":"374","author":"L Zheng","year":"2021","unstructured":"Zheng, L. et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science 374, abe6474 (2021).","journal-title":"Science"},{"key":"9926_CR23","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.cell.2021.02.019","volume":"184","author":"Z Chen","year":"2021","unstructured":"Chen, Z. et al. In vivo CD8(+) T cell CRISPR screening reveals control by Fli1 in infection and cancer. Cell 184, 1262\u20131280 (2021).","journal-title":"Cell"},{"key":"9926_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature08097","volume":"460","author":"EL Pearce","year":"2009","unstructured":"Pearce, E. L. et al. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 460, 103\u2013107 (2009).","journal-title":"Nature"},{"key":"9926_CR25","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/s41423-023-01093-y","volume":"20","author":"J Yu","year":"2023","unstructured":"Yu, J. et al. The OX40-TRAF6 axis promotes CTLA-4 degradation to augment antitumor CD8(+) T-cell immunity. Cell Mol. Immunol. 20, 1445\u20131456 (2023).","journal-title":"Cell Mol. Immunol."},{"key":"9926_CR26","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2018100978","volume":"38","author":"X He","year":"2019","unstructured":"He, X. et al. RNF34 functions in immunity and selective mitophagy by targeting MAVS for autophagic degradation. EMBO J. 38, e100978 (2019).","journal-title":"EMBO J."},{"key":"9926_CR27","doi-asserted-by":"publisher","first-page":"325","DOI":"10.15698\/cst2018.11.164","volume":"2","author":"H Han","year":"2018","unstructured":"Han, H., Chae, S., Hwang, D. & Song, J. Attenuating MKRN1 E3 ligase-mediated AMPKalpha suppression increases tolerance against metabolic stresses in mice. Cell Stress 2, 325\u2013328 (2018).","journal-title":"Cell Stress"},{"key":"9926_CR28","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1080\/15548627.2024.2423329","volume":"21","author":"W Wang","year":"2025","unstructured":"Wang, W., Liu, J., Li, J. & Su, H. A PRKN-independent mechanism regulating cardiac mitochondrial quality control. Autophagy 21, 254\u2013256 (2025).","journal-title":"Autophagy"},{"key":"9926_CR29","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41556-018-0084-5","volume":"20","author":"J Choi","year":"2018","unstructured":"Choi, J. et al. Loss of KLHL6 promotes diffuse large B-cell lymphoma growth and survival by stabilizing the mRNA decay factor roquin2. Nat. Cell Biol. 20, 586\u2013596 (2018).","journal-title":"Nat. Cell Biol."},{"key":"9926_CR30","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.4049\/jimmunol.1700708","volume":"199","author":"B Bertocci","year":"2017","unstructured":"Bertocci, B. et al. Klhl6 deficiency impairs transitional B cell survival and differentiation. J. Immunol. 199, 2408\u20132420 (2017).","journal-title":"J. Immunol."},{"key":"9926_CR31","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.immuni.2016.07.008","volume":"45","author":"B Bengsch","year":"2016","unstructured":"Bengsch, B. et al. Bioenergetic insufficiencies due to metabolic alterations regulated by the inhibitory receptor PD-1 are an early driver of CD8(+) T cell exhaustion. Immunity 45, 358\u2013373 (2016).","journal-title":"Immunity"},{"key":"9926_CR32","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/s41590-024-01843-8","volume":"25","author":"X Lan","year":"2024","unstructured":"Lan, X. et al. Antitumor progenitor exhausted CD8(+) T cells are sustained by TCR engagement. Nat. Immunol. 25, 1046\u20131058 (2024).","journal-title":"Nat. Immunol."},{"key":"9926_CR33","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","volume":"20","author":"BC Miller","year":"2019","unstructured":"Miller, B. C. et al. Subsets of exhausted CD8(+) T cells differentially mediate tumor control and respond to checkpoint blockade. Nat. Immunol. 20, 326\u2013336 (2019).","journal-title":"Nat. Immunol."},{"key":"9926_CR34","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1200\/JCO.2010.32.2537","volume":"29","author":"PF Robbins","year":"2011","unstructured":"Robbins, P. F. et al. Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. J. Clin. Oncol. 29, 917\u2013924 (2011).","journal-title":"J. Clin. Oncol."},{"key":"9926_CR35","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1016\/j.immuni.2023.11.005","volume":"56","author":"JC Beltra","year":"2023","unstructured":"Beltra, J. C. et al. Stat5 opposes the transcription factor Tox and rewires exhausted CD8(+) T cells toward durable effector-like states during chronic antigen exposure. Immunity 56, 2699\u20132718 (2023).","journal-title":"Immunity"},{"key":"9926_CR36","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.immuni.2020.04.014","volume":"52","author":"JC Beltra","year":"2020","unstructured":"Beltra, J. C. et al. Developmental relationships of four exhausted CD8(+) T cell subsets reveals underlying transcriptional and epigenetic landscape control mechanisms. Immunity 52, 825\u2013841 (2020).","journal-title":"Immunity"},{"key":"9926_CR37","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/s41589-024-01590-9","volume":"20","author":"HT Huang","year":"2024","unstructured":"Huang, H. T. et al. Ubiquitin-specific proximity labeling for the identification of E3 ligase substrates. Nat. Chem. Biol. 20, 1227\u20131236 (2024).","journal-title":"Nat. Chem. Biol."},{"key":"9926_CR38","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1324-y","volume":"571","author":"AC Scott","year":"2019","unstructured":"Scott, A. C. et al. TOX is a critical regulator of tumour-specific T cell differentiation. Nature 571, 270\u2013274 (2019).","journal-title":"Nature"},{"key":"9926_CR39","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-019-1326-9","volume":"571","author":"F Alfei","year":"2019","unstructured":"Alfei, F. et al. TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection. Nature 571, 265\u2013269 (2019).","journal-title":"Nature"},{"key":"9926_CR40","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1182\/blood-2017-10-813139","volume":"131","author":"M Ying","year":"2018","unstructured":"Ying, M. et al. Ubiquitin-dependent degradation of CDK2 drives the therapeutic differentiation of AML by targeting PRDX2. Blood 131, 2698\u20132711 (2018).","journal-title":"Blood"},{"key":"9926_CR41","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1182\/blood.2022018752","volume":"142","author":"N Zhou","year":"2023","unstructured":"Zhou, N. et al. DLBCL-associated NOTCH2 mutations escape ubiquitin-dependent degradation and promote chemoresistance. Blood 142, 973\u2013988 (2023).","journal-title":"Blood"},{"key":"9926_CR42","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.ado3032","volume":"10","author":"YJ Huang","year":"2025","unstructured":"Huang, Y. J. et al. Continuous expression of TOX safeguards exhausted CD8 T cell epigenetic fate. Sci. Immunol. 10, eado3032 (2025).","journal-title":"Sci. Immunol."},{"key":"9926_CR43","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/ncb2422","volume":"14","author":"L Liu","year":"2012","unstructured":"Liu, L. et al. Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nat. Cell Biol. 14, 177\u2013185 (2012).","journal-title":"Nat. Cell Biol."},{"key":"9926_CR44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cell.2016.05.035","volume":"166","author":"MD Buck","year":"2016","unstructured":"Buck, M. D. et al. Mitochondrial dynamics controls T cell fate through metabolic programming. Cell 166, 63\u201376 (2016).","journal-title":"Cell"},{"key":"9926_CR45","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.cell.2011.11.030","volume":"148","author":"Z Wang","year":"2012","unstructured":"Wang, Z., Jiang, H., Chen, S., Du, F. & Wang, X. The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways. Cell 148, 228\u2013243 (2012).","journal-title":"Cell"},{"key":"9926_CR46","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41418-019-0396-4","volume":"27","author":"K Ma","year":"2020","unstructured":"Ma, K. et al. Dynamic PGAM5 multimers dephosphorylate BCL-xL or FUNDC1 to regulate mitochondrial and cellular fate. Cell Death Differ. 27, 1036\u20131051 (2020).","journal-title":"Cell Death Differ."},{"key":"9926_CR47","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.molcel.2014.02.034","volume":"54","author":"G Chen","year":"2014","unstructured":"Chen, G. et al. A regulatory signaling loop comprising the PGAM5 phosphatase and CK2 controls receptor-mediated mitophagy. Mol. Cell 54, 362\u2013377 (2014).","journal-title":"Mol. Cell"},{"key":"9926_CR48","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1016\/j.apsb.2021.01.008","volume":"11","author":"C Gao","year":"2021","unstructured":"Gao, C. et al. A novel PGAM5 inhibitor LFHP-1c protects blood\u2013brain barrier integrity in ischemic stroke. Acta Pharm. Sin. B 11, 1867\u20131884 (2021).","journal-title":"Acta Pharm. Sin. B"},{"key":"9926_CR49","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.cmet.2005.05.004","volume":"1","author":"J Lin","year":"2005","unstructured":"Lin, J., Handschin, C. & Spiegelman, B. M. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab. 1, 361\u2013370 (2005).","journal-title":"Cell Metab."},{"key":"9926_CR50","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.immuni.2016.07.009","volume":"45","author":"NE Scharping","year":"2016","unstructured":"Scharping, N. E. et al. The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction. Immunity 45, 374\u2013388 (2016).","journal-title":"Immunity"},{"key":"9926_CR51","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nrc.2017.105","volume":"18","author":"D Senft","year":"2018","unstructured":"Senft, D., Qi, J. & Ronai, Z. A. Ubiquitin ligases in oncogenic transformation and cancer therapy. Nat. Rev. Cancer 18, 69\u201388 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"9926_CR52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41392-020-0107-0","volume":"5","author":"L Deng","year":"2020","unstructured":"Deng, L., Meng, T., Chen, L., Wei, W. & Wang, P. The role of ubiquitination in tumorigenesis and targeted drug discovery. Signal Transduct. Target. Ther. 5, 11 (2020).","journal-title":"Signal Transduct. Target. Ther."},{"key":"9926_CR53","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s44466-025-00014-0","volume":"1","author":"A Hoffmann","year":"2025","unstructured":"Hoffmann, A., Cheng, G. & Baltimore, D. NF-\u03baB: master regulator of cellular responses in health and disease. Immun. Inflamm. 1, 2 (2025).","journal-title":"Immun. Inflamm."},{"key":"9926_CR54","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41590-021-00888-3","volume":"22","author":"J Zhou","year":"2021","unstructured":"Zhou, J. et al. The ubiquitin ligase MDM2 sustains STAT5 stability to control T cell-mediated antitumor immunity. Nat. Immunol. 22, 460\u2013470 (2021).","journal-title":"Nat. Immunol."},{"key":"9926_CR55","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41586-018-0756-0","volume":"564","author":"X Meng","year":"2018","unstructured":"Meng, X. et al. FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells. Nature 564, 130\u2013135 (2018).","journal-title":"Nature"},{"key":"9926_CR56","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s42255-020-00280-9","volume":"2","author":"F Franco","year":"2020","unstructured":"Franco, F., Jaccard, A., Romero, P., Yu, Y. R. & Ho, P. C. Metabolic and epigenetic regulation of T-cell exhaustion. Nat. Metab. 2, 1001\u20131012 (2020).","journal-title":"Nat. Metab."},{"key":"9926_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16312-7","volume":"11","author":"B Yu","year":"2020","unstructured":"Yu, B. et al. Mitochondrial phosphatase PGAM5 modulates cellular senescence by regulating mitochondrial dynamics. Nat. Commun. 11, 2549 (2020).","journal-title":"Nat. Commun."},{"key":"9926_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.104833","volume":"111","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. In vitro and in vivo degradation of programmed cell death ligand 1 (PD-L1) by a proteolysis targeting chimera (PROTAC). Bioorg. Chem. 111, 104833 (2021).","journal-title":"Bioorg. Chem."},{"key":"9926_CR59","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.ccell.2020.08.001","volume":"38","author":"J Si","year":"2020","unstructured":"Si, J. et al. Hematopoietic progenitor kinase1 (HPK1) mediates T cell dysfunction and is a druggable target for T cell-based immunotherapies. Cancer Cell 38, 551\u2013566 (2020).","journal-title":"Cancer Cell"},{"key":"9926_CR60","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41590-023-01720-w","volume":"25","author":"X Zhao","year":"2024","unstructured":"Zhao, X. et al. The transcriptional cofactor Tle3 reciprocally controls effector and central memory CD8(+\u2009) T cell fates. Nat. Immunol. 25, 294\u2013306 (2024).","journal-title":"Nat. Immunol."},{"key":"9926_CR61","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.immuni.2016.10.028","volume":"45","author":"JP Scott-Browne","year":"2016","unstructured":"Scott-Browne, J. P. et al. Dynamic changes in chromatin accessibility occur in CD8(+) T cells responding to viral infection. Immunity 45, 1327\u20131340 (2016).","journal-title":"Immunity"},{"key":"9926_CR62","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.immuni.2017.11.021","volume":"47","author":"K Man","year":"2017","unstructured":"Man, K. et al. Transcription factor IRF4 promotes CD8(+) T cell exhaustion and limits the development of memory-like T cells during chronic infection. Immunity 47, 1129\u20131141 (2017).","journal-title":"Immunity"},{"key":"9926_CR63","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.immuni.2016.07.021","volume":"45","author":"DT Utzschneider","year":"2016","unstructured":"Utzschneider, D. T. et al. T cell factor 1-expressing memory-like CD8(+) T cells sustain the immune response to chronic viral infections. Immunity 45, 415\u2013427 (2016).","journal-title":"Immunity"},{"key":"9926_CR64","doi-asserted-by":"publisher","first-page":"E2776","DOI":"10.1073\/pnas.1620498114","volume":"114","author":"GP Mognol","year":"2017","unstructured":"Mognol, G. P. et al. Exhaustion-associated regulatory regions in CD8(+) tumor-infiltrating T cells. Proc. Natl Acad. Sci. USA 114, E2776\u2013E2785 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9926_CR65","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s41586-019-0985-x","volume":"567","author":"J Chen","year":"2019","unstructured":"Chen, J. et al. NR4A transcription factors limit CAR T cell function in solid tumours. Nature 567, 530\u2013534 (2019).","journal-title":"Nature"},{"key":"9926_CR66","doi-asserted-by":"publisher","first-page":"13235","DOI":"10.1073\/pnas.1414714111","volume":"111","author":"S Zadran","year":"2014","unstructured":"Zadran, S., Arumugam, R., Herschman, H., Phelps, M. E. & Levine, R. D. Surprisal analysis characterizes the free energy time course of cancer cells undergoing epithelial-to-mesenchymal transition. Proc. Natl Acad. Sci. USA 111, 13235\u201313240 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9926_CR67","doi-asserted-by":"publisher","first-page":"10324","DOI":"10.1073\/pnas.1005283107","volume":"107","author":"F Remacle","year":"2010","unstructured":"Remacle, F., Kravchenko-Balasha, N., Levitzki, A. & Levine, R. D. Information-theoretic analysis of phenotype changes in early stages of carcinogenesis. Proc. Natl Acad. Sci. USA 107, 10324\u201310329 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9926_CR68","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9926_CR69","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"9926_CR70","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.cell.2015.02.038","volume":"160","author":"S Chen","year":"2015","unstructured":"Chen, S. et al. Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis. Cell 160, 1246\u20131260 (2015).","journal-title":"Cell"},{"key":"9926_CR71","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41586-019-1821-z","volume":"576","author":"J Wei","year":"2019","unstructured":"Wei, J. et al. Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy. Nature 576, 471\u2013476 (2019).","journal-title":"Nature"},{"key":"9926_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0843-6","volume":"16","author":"W Li","year":"2015","unstructured":"Li, W. et al. Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR. Genome Biol. 16, 281 (2015).","journal-title":"Genome Biol."},{"key":"9926_CR73","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"9926_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15956-9","volume":"11","author":"Y Su","year":"2020","unstructured":"Su, Y. et al. Multi-omic single-cell snapshots reveal multiple independent trajectories to drug tolerance in a melanoma cell line. Nat. Commun. 11, 2345 (2020).","journal-title":"Nat. Commun."},{"key":"9926_CR75","doi-asserted-by":"crossref","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 17, 10\u201312 (2011).","DOI":"10.14806\/ej.17.1.200"},{"key":"9926_CR76","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"9926_CR77","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation 2, 100141 (2021).","journal-title":"Innovation"},{"key":"9926_CR78","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","volume":"185","author":"Y Su","year":"2022","unstructured":"Su, Y. et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 185, 881\u2013895 (2022).","journal-title":"Cell"},{"key":"9926_CR79","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.cell.2020.10.037","volume":"183","author":"Y Su","year":"2020","unstructured":"Su, Y. et al. Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19. Cell 183, 1479\u20131495 (2020).","journal-title":"Cell"},{"key":"9926_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1382-0","volume":"19","author":"FA Wolf","year":"2018","unstructured":"Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 19, 15 (2018).","journal-title":"Genome Biol."},{"key":"9926_CR81","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09926-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09926-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09926-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T21:02:33Z","timestamp":1773262953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09926-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":81,"journal-issue":{"issue":"8105","published-print":{"date-parts":[[2026,3,12]]}},"alternative-id":["9926"],"URL":"https:\/\/doi.org\/10.1038\/s41586-025-09926-8","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"29 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.D.G. is a founder of and has received funding from Juno Therapeutics; is a founder and scientific advisory board member of, has equity in and has received research support from Affini-T Therapeutics; is an scientific advisory board member of and has equity in Immunoscape, Elpiscience, Earli, Metagenomi, Nextech and Catalio; and has received research support from Lonza. R.G. has received consulting income from Takeda, Sanofi and declares ownership in Ozette Technologies and stock options in Modulus Therapeutics. G.L., H.C. and X.P. have a pending patent application filed related to this work. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}